Fachapotheker In FPH Spital Practice Questions - Fachapotheker In FPH In Spitalpharmazie Pharmacien Ne Spécialiste FPH En Pharmacie Hospitalière Exam

Access More Questions

Under the Swiss Health Insurance Ordinance (Art. 71a–71d KVV / OAMal), when an oncologist requests inpatient off-label reimbursement for an expensive oncology drug outside its Swissmedic-approved indication, which criterion must be fulfilled for mandatory reimbursement by the statutory health insurer (OKP)?

The medication must be listed on the Swiss Specialty List (Spezialitätenliste, SL) for that specific indication with an established SwissDRG flat rebate The clinical trial evaluating the drug must be fully sponsored by the Swiss National Science Foundation (SNF) and completed in a Swiss university hospital The therapy is expected to provide a major therapeutic benefit against a fatal or chronic severe disease, and no approved, effective, and reimbursable alternative therapy exists The hospital's Arzneimittelkommission (AMK) must unanimously vote to cover 100% of the medication acquisition costs from its general operating budget

Correct Answer:

The therapy is expected to provide a major therapeutic benefit against a fatal or chronic severe disease, and no approved, effective, and reimbursable alternative therapy exists

Access more questions from this quiz

Continue to Fachapotheker in FPH Spital Practice Questions - Fachapotheker in FPH in Spitalpharmazie Pharmacien ne spécialiste FPH en pharmacie hospitalière Exam for more practice questions and the full quiz experience.

Access More Questions